Galderma Launches Sculptra in China
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
Brian Pilcher, PhD, discusses Conexeu’s CXU platform and what 3D-printed extracellular matrix technology could mean for future reconstructive and aesthetic surgery.